A double-blind, placebo-controlled single dose trial of intravenous flumazenil in Alzheimer's disease
- 23 June 1999
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 14 (4) , 239-245
- https://doi.org/10.1002/(sici)1099-1077(199906)14:4<239::aid-hup94>3.0.co;2-r
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist flumazenilPsychopharmacology, 1995
- Positron Emission Tomography Measures of Benzodiazepine Binding in Alzheimer's DiseaseArchives of Neurology, 1995
- The Interactions of Midazolam and Flumazenil on Human Memory and CognitionAnesthesiology, 1993
- NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortexNeurobiology of Aging, 1993
- FlumazenilDrugs, 1991
- Pharmacokinetics and EEG Effects of Flumazenil in VolunteersClinical Pharmacokinetics, 1991
- Flumazenil Provocation of Panic AttacksArchives of General Psychiatry, 1990
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975
- Sensitivity and responsivity measures for discrimination learningLearning and Motivation, 1973